FEDERAL COURT OF AUSTRALIA
F. Hoffman-La Roche AG v New England Biolabs Inc [1999] FCA 1424
PATENTS – application for appointment of independent assessor under s217 Patents Act 1990 – discussion of function of assessor – procedure to be adopted for approaching prospective assessors - whether Court should order applicant for patent to produce statement of invention – whether applicant for patent should only have to rely on specification itself as disclosing invention
Patents Act 1990 (Cth), s 217, s 40
Genetic Institute Inc v Kirin-Amgen Inc (No.2) (1997) 78 FCR 368, referred to
Genetics Institute Inc v Kirin-Amgen Inc (No.3) (1998) 156 ALR 30, referred toF. HOFFMAN-LA ROCHE AG v NEW ENGLAND BIOLABS, INC
NG947 OF 1997
NEW ENGLAND BIOLABS, INC v F. HOFFMAN-LA ROCHE
NG1035 OF 1997EMMETT J
13 OCTOBER 1999
SYDNEY
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
NG 947 OF 1997
BETWEEN:
F. HOFFMAN-LA ROCHE AG
ApplicantAND:
NEW ENGLAND BIOLABS, INC
RespondentNG 1035 OF 1997
BETWEEN:
NEW ENGLAND BIOLABS, INC
ApplicantAND:
F. HOFFMAN-LA ROCHE AG
RespondentJUDGE:
EMMETT J
DATE OF ORDER:
13 OCTOBER 1999
WHERE MADE:
SYDNEY
THE COURT ORDERS THAT:
1.New England Biolabs, Inc furnish to F. Hoffman-La Roche AG within 14 days a list of independent persons suggested as being qualified to act as an assessor pursuant to section 217 Patents Act 1990.
2.F. Hoffman-La Roche AG within 14 days of receipt of the list indicate whether any of the independent persons are acceptable, and if not, furnish an alternative list.
3.If there is no agreement as to the identity of the person to be approached, there be liberty to apply to restore the matter to the list.
4.Both parties furnish to Emmett J’s associate within 21 days a proposed form of letter to be addressed to prospective assessors informing the addressee of the nature of the patent and the terms of section 217, inviting the addressee to indicate his or her qualifications, and enquiring whether the addressee is available and willing to act in the capacity of assessor.
5.Each party notify the other if any person on the list of independent persons has been or will be approached by that party in connection with these proceedings.
6.The proceedings be stood over for directions generally on 10 December 1999 at 9.30am.
7.The motion filed by New England Biolabs, Inc be stood over part-heard to 10 December 1999 at 9.30am for directions only.
Note:Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
NG 947 OF 1997
BETWEEN:
F. HOFFMAN-LA ROCHE AG
ApplicantAND:
NEW ENGLAND BIOLABS, INC
Respondent
NG 1035 OF 1997
BETWEEN:
NEW ENGLAND BIOLABS, INC
ApplicantAND:
F. HOFFMAN-LA ROCHE AG
Respondent
JUDGE:
EMMETT J
DATE:
13 OCTOBER 1999
PLACE:
SYDNEY
REASONS FOR JUDGMENT
F. Hoffmann-La Roche AG (“Hoffman-La Roche”) is the assignee of an application for a patent which has been assigned…
Keep reading for free
Create a free CaseChat account to read F. Hoffman-La Roche AG v New England Biolabs Inc and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1999] FCA 1424
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the court was the interpretation and application of section 217 of the Patents Act 1990. Specifically, the court needed to determine the procedure for selecting an assessor when the parties could not agree on a suitable candidate. The court had to ensure that the process was fair and adhered to the statutory requirements, while also facilitating a timely resolution of the underlying patent dispute.
The court issued detailed orders to facilitate the selection of an assessor. New England Biolabs, Inc was required to provide a list of independent persons who were qualified to act as an assessor. F. Hoffman-La Roche AG was then to indicate whether any of these persons were acceptable, or alternatively, provide a list of acceptable candidates. If the parties could not agree on an assessor, the court granted liberty to apply for the matter to be restored to the list. The court also mandated the exchange of proposed forms of letters to be sent to prospective assessors and required both parties to notify each other if any person on the list was approached in connection with these proceedings. The proceedings were stood over for directions to be heard on 10 December 1999 at 9.30am, and the motion filed by New England Biolabs, Inc was also stood over part-heard to the same date and time for directions only.
The court's orders aimed to ensure a structured and transparent process for selecting an assessor, thereby facilitating the efficient resolution of the underlying patent dispute. The orders reflected the court's commitment to adhering to the statutory requirements and promoting a fair and expeditious resolution of the matter.
Orders
Orders of the court
1. New England Biolabs, Inc furnish to F. Hoffman-La Roche AG within 14 days a list of independent persons suggested as being qualified to act as an assessor pursuant to section 217 Patents Act 1990.
2. F. Hoffman-La Roche AG within 14 days of receipt of the list indicate whether any of the independent persons are acceptable, and if not, furnish an alternative list.
3. If there is no agreement as to the identity of the person to be approached, there be liberty to apply to restore the matter to the list.
4. Both parties furnish to Emmett J’s associate within 21 days a proposed form of letter to be addressed to prospective assessors informing the addressee of the nature of the patent and the terms of section 217, inviting the addressee to indicate his or her qualifications, and enquiring whether the addressee is available and willing to act in the capacity of assessor.
5. Each party notify the other if any person on the list of independent persons has been or will be approached by that party in connection with these proceedings.
6. The proceedings be stood over for directions generally on 10 December 1999 at 9.30am.
7. The motion filed by New England Biolabs, Inc be stood over part-heard to 10 December 1999 at 9.30am for directions only.
Note: Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Established by: EMMETT J
Full text does not contain this section.